KP415.E01: "A Multicenter, Dose-optimized, double-blind, randomized, placebo-controlled, parallel efficacy laboratory classroom study with KP415 in children with attention-deficit/hyperactivity disorder"

Administered By

Awarded By

Contributors

Start/End

  • November 7, 2017 - October 1, 2019